Andreia Brandão

ORCID: 0000-0003-0938-1543 · 2 papers in corpus · active 2021
2021
·doi:10.1101/2021.09.04.458979

Bladder cancer (BC) management demands the introduction of novel molecular targets for precision medicine. Cell surface glycoprotein CD44 has been widely studied as a potential biomarker of BC aggressiveness and cancer stem cells. However, …

2021
Frontiers in oncology ·doi:10.3389/fonc.2021.754094

Genetic testing to detect somatic alterations is usually performed on formalin-fixed paraffin-embedded tumor samples. However, tumor molecular profiling through ctDNA analysis may be particularly interesting with the emergence of targeted t…